143 related articles for article (PubMed ID: 29969609)
1. Wnt signaling in bone metastasis: mechanisms and therapeutic opportunities.
Li X; Yang J; Bao M; Zeng K; Fu S; Wang C; Ye L
Life Sci; 2018 Sep; 208():33-45. PubMed ID: 29969609
[TBL] [Abstract][Full Text] [Related]
2. Wnt signaling pathway: implications for therapy in lung cancer and bone metastasis.
Xi Y; Chen Y
Cancer Lett; 2014 Oct; 353(1):8-16. PubMed ID: 25042867
[TBL] [Abstract][Full Text] [Related]
3. Targeting the Wnt signaling pathway for breast cancer bone metastasis therapy.
Cui J; Chen H; Zhang K; Li X
J Mol Med (Berl); 2022 Mar; 100(3):373-384. PubMed ID: 34821953
[TBL] [Abstract][Full Text] [Related]
4. Antagonizing miR-218-5p attenuates Wnt signaling and reduces metastatic bone disease of triple negative breast cancer cells.
Taipaleenmäki H; Farina NH; van Wijnen AJ; Stein JL; Hesse E; Stein GS; Lian JB
Oncotarget; 2016 Nov; 7(48):79032-79046. PubMed ID: 27738322
[TBL] [Abstract][Full Text] [Related]
5. Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer.
Johnson RW; Merkel AR; Page JM; Ruppender NS; Guelcher SA; Sterling JA
Clin Exp Metastasis; 2014 Dec; 31(8):945-59. PubMed ID: 25359619
[TBL] [Abstract][Full Text] [Related]
6. Functionalized curcumin analogs as potent modulators of the Wnt/β-catenin signaling pathway.
Leow PC; Bahety P; Boon CP; Lee CY; Tan KL; Yang T; Ee PL
Eur J Med Chem; 2014 Jan; 71():67-80. PubMed ID: 24275249
[TBL] [Abstract][Full Text] [Related]
7. [Regulation of Wnt/β-catenin signaling in bone development and bone tumor].
Zhou ZH; Xiao JR
Zhonghua Wai Ke Za Zhi; 2018 Oct; 56(10):797-800. PubMed ID: 30369164
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of oleandrin on the proliferation show and invasion of osteosarcoma cells in vitro by suppressing Wnt/β-catenin signaling pathway.
Ma Y; Zhu B; Liu X; Yu H; Yong L; Liu X; Shao J; Liu Z
J Exp Clin Cancer Res; 2015 Oct; 34():115. PubMed ID: 26444270
[TBL] [Abstract][Full Text] [Related]
9. Icariin promotes osteogenic differentiation of rat bone marrow stromal cells by activating the ERα-Wnt/β-catenin signaling pathway.
Wei Q; Zhang J; Hong G; Chen Z; Deng W; He W; Chen MH
Biomed Pharmacother; 2016 Dec; 84():931-939. PubMed ID: 27764755
[TBL] [Abstract][Full Text] [Related]
10. The Wnt signaling pathway: implications for therapy in osteosarcoma.
McQueen P; Ghaffar S; Guo Y; Rubin EM; Zi X; Hoang BH
Expert Rev Anticancer Ther; 2011 Aug; 11(8):1223-32. PubMed ID: 21916576
[TBL] [Abstract][Full Text] [Related]
11. Wnt signaling in osteosarcoma.
Lin CH; Ji T; Chen CF; Hoang BH
Adv Exp Med Biol; 2014; 804():33-45. PubMed ID: 24924167
[TBL] [Abstract][Full Text] [Related]
12. Wnt Signaling in the Development of Bone Metastasis.
Ben-Ghedalia-Peled N; Vago R
Cells; 2022 Dec; 11(23):. PubMed ID: 36497192
[TBL] [Abstract][Full Text] [Related]
13. Antitumor Effect of Docetaxel in Osteosarcoma by the Inhibition of Wnt Signal Channel.
Wang DZ; Gao JF; Jing SF; Wei H; Huang XY; Li CD
Drug Res (Stuttg); 2015 Nov; 65(11):597-601. PubMed ID: 25514117
[TBL] [Abstract][Full Text] [Related]
14. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
[TBL] [Abstract][Full Text] [Related]
15. Differential effects on lung and bone metastasis of breast cancer by Wnt signalling inhibitor DKK1.
Zhuang X; Zhang H; Li X; Li X; Cong M; Peng F; Yu J; Zhang X; Yang Q; Hu G
Nat Cell Biol; 2017 Oct; 19(10):1274-1285. PubMed ID: 28892080
[TBL] [Abstract][Full Text] [Related]
16. Wnt pathway in osteosarcoma, from oncogenic to therapeutic.
Cai Y; Cai T; Chen Y
J Cell Biochem; 2014 Apr; 115(4):625-31. PubMed ID: 24190862
[TBL] [Abstract][Full Text] [Related]
17. Dihydromyricetin enhances the osteogenic differentiation of human bone marrow mesenchymal stem cells in vitro partially via the activation of Wnt/β-catenin signaling pathway.
Zhang W; Wang S; Yin H; Chen E; Xue D; Zheng Q; Gao X; Pan Z
Fundam Clin Pharmacol; 2016 Dec; 30(6):596-606. PubMed ID: 27469984
[TBL] [Abstract][Full Text] [Related]
18. Wnt signaling pathway inhibitors as promising diagnostic serum markers of osteolytic bone metastasis.
Galliera E; Marazzi MG; Drago L; Banfi G; Luzzati A; Corsi Romanelli MM
J Biol Regul Homeost Agents; 2016; 30(2):399-408. PubMed ID: 27358126
[TBL] [Abstract][Full Text] [Related]
19. Prodigiosin inhibits Wnt/β-catenin signaling and exerts anticancer activity in breast cancer cells.
Wang Z; Li B; Zhou L; Yu S; Su Z; Song J; Sun Q; Sha O; Wang X; Jiang W; Willert K; Wei L; Carson DA; Lu D
Proc Natl Acad Sci U S A; 2016 Nov; 113(46):13150-13155. PubMed ID: 27799526
[TBL] [Abstract][Full Text] [Related]
20. Berberine promotes bone marrow-derived mesenchymal stem cells osteogenic differentiation via canonical Wnt/β-catenin signaling pathway.
Tao K; Xiao D; Weng J; Xiong A; Kang B; Zeng H
Toxicol Lett; 2016 Jan; 240(1):68-80. PubMed ID: 26478571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
